Caitlin Cronin

Stock Analyst at Canaccord Genuity

(0.47)
# 2500
Out of 5,347 analysts
28
Total ratings
43.75%
Success rate
-1.20%
Average return
12 Stocks
Name Action PT Current % Upside Ratings Updated
ENOV Enovis
Maintains: Buy
75 70
31.29 123.71% 2 May 14, 2025
AXGN Axogen
Maintains: Buy
26 24
10.88 120.59% 5 May 13, 2025
SNN Smith & Nephew
Maintains: Hold
27 28
28.95 -3.28% 2 May 1, 2025
INMD InMode
Maintains: Hold
17 15
14.66 2.32% 3 Apr 29, 2025
TELA TELA Bio
Maintains: Buy
12 7
1.39 403.6% 4 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 15
6.47 131.84% 1 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
64 67
41.29 62.27% 3 Feb 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 4
2.71 47.6% 2 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 20
12.42 61.03% 3 Aug 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
130
92.16 41.06% 1 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
79
59.2 33.45% 1 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
270 12
7.76 54.64% 1 Nov 14, 2023